MYC and familial pancreatic carcinoma: A study reported that NEDD4 targets Myc oncoproteins, c-Myc and N-Myc, for degradation by directly binding to them, which resulted in downregulation of these proteins and suppression of cell proliferation in pancreatic cancer and neuroblastoma [63,103].